Glycemic Excursion Minimization (GEM) to Outshine Health Disparities
Part of paid clinical trials in Augusta, Georgia.
- Sponsor
- Catherine Davis
- Study ID
- NCT06236581
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- GEM Intervention — BEHAVIORALLifestyle coaching
Study Details
The purpose of this study is to see if the GEM intervention is acceptable and helpful to Black adults with type 2 diabetes. The GEM intervention (coaching to reduce carbohydrate intake and increase physical activity after meals, with feedback from a continuous glucose monitor, CGM) might improve blood glucose levels, reduce diabetes distress, and increase empowerment and confidence in managing diabetes.
Key Dates
- Start date
- Jun 20, 2024
- Status verified
- Jul 2024
- Primary completion
- Dec 31, 2024
- Completion
- Dec 31, 2024
Study Design
- Enrollment
- 25 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: GEM InterventionA lifestyle coach will deliver the GEM intervention over 4 weeks in person and/or virtually (synchronously) to permit interaction with participants. A pocket-sized manual will be provided with 4 units corresponding to session topics, and diary pages to record glucose responses to food and physical activity (PA). Session 1: Introduce GEM, identify personal motivation, learn about foods that cause glucose to go high (high glycemic load (GL) foods) and those that do not (low GL foods), learn how physical activity affects glucose, and begin monitoring how these choices affect glucose. Session 2: Replacement, substitution, and portion control to reduce consumption of high GL foods. Session 3: Increasing PA and reducing sedentary behavior, esp. after a meal. Session 4: Ways to continue lifestyle changes over a lifetime, handle relapses, and thank loved ones for their support. Text message reminders may be sent to participants between sessions to prompt diary entries and for encouragement.
- No Intervention: WaitlistParticipants will be invited to receive the GEM intervention after they posttest, the next time it is offered.
Primary Outcome Measure
Change from baseline on percent time in range from continuous glucose monitor at post-intervention [ Time Frame: Baseline week and post-intervention week. From baseline week to the week after end of intervention or waitlist period, up to 6 weeks ]
Central Contacts
- Catherine L Davis, PhD706-721-4534
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Georgia Prevention Institute | Augusta | Georgia | 30912 | Andre Soares, PT MS 706-721-4534 Catherine L Davis, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Augusta, GA
By condition
By specialty
By research site
Related Studies
- Effectiveness and Safety of the RIGHTEST Continuous Glucose Monitoring System for Blood Glucose Management in Persons With Diabetes MellitusNot Yet Recruiting · Bionime Corporation · Guntersville, Alabama
- Mobile App Logging for Diabetes in PregnancyRecruiting · Carolyn Zahler-Miller · Augusta, Georgia
- A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)PHASE3 · Recruiting · Eli Lilly and Company · Tucson, Arizona
- A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or TirzepatidePHASE2 · Recruiting · Eli Lilly and Company · Phoenix, Arizona